Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 5/20 | 0.39 |
| ▸ | BACE1 | P56817 | 1/20 | 0.38 |
| ▸ | GPR119 | Q8TDV5 | 3/20 | 0.37 |
| ▸ | HTR2C | P28335 | 4/20 | 0.37 |
| ▸ | HTR2A | P28223 | 3/20 | 0.37 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.37 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.37 |
| ▸ | DRD2 | P14416 | 2/20 | 0.36 |
| ▸ | MMP13 | P45452 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5637776 | 0.82 | USP30 (0.49) | USP30MAPTHTR2CHTR2ADRD2 | |
| SCHEMBL5636199 | 0.82 | CNR1 (0.42) | USP30MAPTGPR119TP53 | |
| SCHEMBL5636646 | 0.82 | USP30 (0.47) | USP30MAPTGPR119HTR2CHTR2A | |
| SCHEMBL5636189 | 0.82 | USP30 (0.45) | USP30MAPTGPR119TP53THRB | |
| SCHEMBL5636575 | 0.80 | USP30 (0.44) | USP30MAPTGPR119TP53THRB | |
| SCHEMBL5636070 | 0.79 | USP30 (0.39) | USP30MAPTGPR119MMP13TP53 | |
| SCHEMBL5636475 | 0.79 | USP30 (0.44) | USP30MAPTGPR119 | |
| SCHEMBL5637027 | 0.79 | USP30 (0.46) | USP30MAPTTP53 | |
| SCHEMBL5635404 | 0.79 | USP30 (0.39) | USP30MAPTGPR119HTR2CHTR2A | |
| SCHEMBL5636801 | 0.79 | HTR2C (0.36) | HTR2CHTR2ADRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE39679-E1 | Substituted heterocycle fused gamma-carbolines | BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) | 2007-06-05 | — | — | US | disclosed |
| US-6713471-B1 | SUCH AS TERT-BUTYL-1-METHYL-6,7,9,12-TETRAHYDRO-5H-PYRIDO-(4,3-B)(1,4) THIAZEPINO(2,3,4-HI)INDOLE-11(10H)-CARBOXYLATE; SEROTONIN AGONISTS AND ANTAGONISTS; CENTRAL NERVOUS SYSTEM DISORDERS | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2004-03-30 | — | — | US | disclosed |